Spyre Therapeutics is based in Cambridge, MA. It has raised $644M in total funding. Latest round: Growth.
Spyre Therapeutics funding overview
Spyre Therapeutics is based in Cambridge, MA. Spyre Therapeutics has raised $644M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Growth announced in January 2024. The round record for Spyre Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include Access Biotechnology, Venrock Healthcare Capital Partners, Perceptive Advisors, RTW Investments, Braidwell, Fairmount and 8 others. 14 distinct backers are named across the disclosed rounds.
Spyre Therapeutics at a glance
Total raised
$644M
Latest round
Growth
Latest round date
January 2024
Headquarters
Cambridge, MA
Notable investors
Access Biotechnology, Venrock Healthcare Capital Partners, Perceptive Advisors, RTW Investments, Braidwell, Fairmount, Cormorant Asset Management, Polar Capital
Frequently asked about Spyre Therapeutics funding
How much has Spyre Therapeutics raised?
Spyre Therapeutics has raised $644M in total disclosed funding across the rounds on record.
Who has invested in Spyre Therapeutics?
Access Biotechnology, Venrock Healthcare Capital Partners, Perceptive Advisors, RTW Investments, Braidwell, Fairmount are named among the investors backing Spyre Therapeutics.
What was the latest Spyre Therapeutics funding round?
The most recent disclosed round is a Growth, announced in January 2024.
Where is Spyre Therapeutics based?
Spyre Therapeutics is based in Cambridge, MA.
When did Spyre Therapeutics last raise?
The last disclosed Spyre Therapeutics round closed in January 2024 at Growth.
Every Spyre Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Cambridge at a similar stage.
